stent

The Fellow’s Corner | 3rd Clinical Case: True Bifurcation Lesion: Which Strategy Should We Use?

Here is the third Fellow’s Corner clinical case to keep discussing and learning alongside the entire community of hemodynamics fellows in Latin America. In this instance, we will present a case of True Bifurcation Lesion: Which Strategy Should We Use? Content 1- Case Presentation 2- Case Resolution 3- Expert Commentary Authors: Dr. Carlos Fava (ARG)<a href="https://solaci.org/en/2021/07/05/the-fellows-corner-3rd-clinical-case-true-bifurcation-lesion-which-strategy-should-we-use/" title="Read more" >...</a>

Síntomas persistentes post COVID-19: mucho más frecuentes de lo que creíamos

Myocarditis and mRNA COVID-19 Vaccines: New Information from the CDC

According to the CDC (Center for Disease Control and Prevention), even though rare, a relationship between myocarditis and mRNA COVID-19 Vaccines definitely exists. Such risk is more prevalent among men, teenagers and young adults a few days following the second dose.&nbsp; Globally, the risk is low: 4.4 of cases per million after the first dose<a href="https://solaci.org/en/2021/07/01/myocarditis-and-mrna-covid-19-vaccines-new-information-from-the-cdc/" title="Read more" >...</a>

DKCRUSH-V: El tronco de la coronaria izquierda no es una bifurcación más

Bifurcations: A Long Return Journey

When it looked like the simplest techniques reach the best outcomes, along came the DK Crush studies. Indeed, after the COVIS III results in bifurcations, it appeared we had started to retrace our steps back to the foundation.&nbsp; The purpose of this study was to compare long term outcomes of the remarkably simple 1-stent strategy<a href="https://solaci.org/en/2021/06/29/bifurcations-a-long-return-journey/" title="Read more" >...</a>

SOLACI-CACI 2021 Virtual

SOLACI-CACI 2021 VIRTUAL CONGRESS &#8211; Registration is Open

You can now register to take part in the largest interventional cardiology event in Latin America! Given the complex and persistent global epidemiological situation caused by the COVID-19 pandemic, for one time only,&nbsp;the event will be open and free (prior registration is required). For one time only, access to the Congress will be completely free<a href="https://solaci.org/en/2021/06/25/solaci-caci-2021-virtual-congress-registration-is-open/" title="Read more" >...</a>

Post-dilatación de válvulas autoexpandibles

Self-Expanding Valve in Extreme Surgical Risk After 5 Years

Patients with aortic stenosis and extreme surgical risk have extremely high mortality due to known comorbidities. The short-term benefit of transcatheter aortic valve replacement (TAVR) with self-expanding valve is clear, and it warrants the procedure in this challenging population. While elderly patients with comorbidities who are at extreme surgical risk might be eligible for TAVR,<a href="https://solaci.org/en/2021/06/24/self-expanding-valve-in-extreme-surgical-risk-after-5-years/" title="Read more" >...</a>

Monto de isquemia basal en pacientes con múltiples vasos y evolución a largo plazo

A Headache for Cardiologists: Ischemia with Non-Obstructive Disease

Treating patients with functional stress test induced ischemia and non-obstructive coronary artery disease (INOCA) is complex and often frustrating.&nbsp; The multifactorial nature of this disease in addition to the complex physiopathological relationship between angina and ischemia turn these patients into a real headache for cardiologists. The CIAO-ISCHEMIA was recently published in Circulation and was designed<a href="https://solaci.org/en/2021/06/16/a-headache-for-cardiologists-ischemia-with-non-obstructive-disease/" title="Read more" >...</a>

SOL SOLACI Program Took Part in the Venezuela Sessions 2021 with a New Charitable Case

SOLACI’s SOLidario Program took part in the XLII Regional SOLACI Sessions in Venezuela, where a charitable intervention was performed in collaboration with the Venezuelan Society of Interventional&nbsp;Cardiology (SOVECI) and&nbsp; Caracas University Hospital. In this opportunity, physicians treated a 60-year-old patient with significant heart disease under study for acute myocardial infarction after thrombolysis. Coronary angiography identified<a href="https://solaci.org/en/2021/06/16/sol-solaci-program-took-part-in-the-venezuela-sessions-2021-with-a-new-charitable-case/" title="Read more" >...</a>

Sangrados mayores en pacientes con AAS más rivaroxabán

AAS vs DAPT post TAVI: Meta-Analysis of Randomized Studies

Aspirin monotherapy (ASA) reduced the combined risk of thrombotic and bleeding events compared against dual antiplatelet therapy (DAPT) in patients receiving transcatheter aortic valve replacement (TAVR). This meta-analysis has only reproduced smaller randomize study outcomes and does not include the OCEAN-TAVI registry, the only one that has shown something different so far.&nbsp; Even though ASA<a href="https://solaci.org/en/2021/06/14/aas-vs-dapt-post-tavi-meta-analysis-of-randomized-studies/" title="Read more" >...</a>

ELUVIA: DES en territorio femoropoplíteo con lesiones complejas

ELUVIA: DES in Complex Femoropopliteal Lesions

Paclitaxel-eluting stent Eluvia showed promising results after two years with a revascularization freedom rate of 80% despite the fact that these were complex femoropopliteal lesions. As the safety of paclitaxel-eluting devices becomes more consistent, more studies on its efficacy are being published. Back in 2018, the safety of paclitaxel-eluting balloons and stents was under scrutiny<a href="https://solaci.org/en/2021/06/12/eluvia-des-in-complex-femoropopliteal-lesions/" title="Read more" >...</a>

Miocardiopatía hipertrófica: análisis de una serie histórica

Differences in American and European Atrial Fibrillation Guidelines

The recent publication of the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) guidelines provided an important update on multiple aspects of the management of atrial fibrillation (AF). However, these guidelines differ in terms of management and recommendation levels. As it might be expected, most differences arose in intermediate cases—both guidelines<a href="https://solaci.org/en/2021/06/07/differences-in-american-and-european-atrial-fibrillation-guidelines/" title="Read more" >...</a>

Top